An experimental gene therapy was found to slow the progression of Huntington’s disease in a “pivotal” study, according to ...

A one-time experimental treatment shows unprecedented success in slowing Huntington's disease, according to UCL researchers.

Preliminary results from a small trial offer the clearest evidence yet that the brain disease’s progression can be slowed.

A pioneering gene therapy has successfully slowed the progression of Huntington’s disease by 75% in patients after three ...

A company called uniQure has announced promising results from a trial of a new gene therapy for Huntington's disease. The ...

A research team from University College London (UCL) in the UK announced on the 24th of last month, local time, that they ...

An experimental gene therapy has slowed the progression of Huntington’s disease by 75 percent, according to results reported ...

A single one-time gene therapy could free patients with α-thalassemia, a rare and debilitating blood disorder, from the ...

New study data showed treatment slowed signs of disease progression by 75% after three years, a finding that could have ...

After three patients died, the maker of an investigational gene therapy stopped shipments of the drug after it refused to ...

D Molecular Therapeutics (FDMT) offers attractive growth potential with strong cash reserves and promising late-stage gene ...

"On the basis of these results, it seems likely AMT-130 will be the first licensed treatment to slow Huntington's disease, ...